Skip to main content

Gemcitabine (International)

In the US, Gemcitabine (gemcitabine systemic) is a member of the drug class antimetabolites and is used to treat Breast Cancer, Breast Cancer - Metastatic, Nasopharyngeal Carcinoma, Non Small Cell Lung Cancer, Ovarian Cancer and Pancreatic Cancer.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01BC05

CAS registry number (Chemical Abstracts Service)

0095058-81-4

Chemical Formula

C9-H11-F2-N3-O4

Molecular Weight

263

Therapeutic Category

Cytostatic agent: Antimetabolite

Chemical Name

Cytidine, 2'-deoxy-2',2'-difluoro-

Foreign Names

Generic Names

Brand Names

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Search international drugs